Factor VIII/Von Willebrand factor overdosePulmonary embolism: case report

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2015年 / 1569卷 / 1期
关键词：
D O I：
10.1007/s40278-015-5452-3
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：108 / 108
相关论文
共 50 条
  • [41] Hypersensitivity to von Willebrand factor and von Willebrand disease: A case-report
    Carneiro-Leao, D.
    Queiros, R.
    Mota, T.
    Fernandes, S.
    Lopes, M.
    Koch, M. D. C.
    HAEMOPHILIA, 2024, 30 : 131 - 132
  • [42] Factor VIII inhibitors:: role of von Willebrand factor on the uptake of factor VIII by dendritic cells
    Kaveri, S. V.
    Dasgupta, S.
    Andre, S.
    Navarrete, A. -M.
    Repesse, Y.
    Wootla, B.
    Lacroix-Desmazes, S.
    HAEMOPHILIA, 2007, 13 : 61 - 64
  • [43] Factor-VIII/von Willebrand factorAnaphylactic reaction followed by successful desensitisation: case report
    Reactions Weekly, 2019, 1762 (1) : 163 - 163
  • [44] Von willebrand factor factor VIII binding is not affected by the Arg89Gln polymorphism in von Willebrand factor
    Nesbitt, IM
    Goodeve, AC
    Preston, FE
    Peake, IR
    THROMBOSIS AND HAEMOSTASIS, 1996, 76 (05) : 820 - 821
  • [45] The factor VIII/Von Willebrand factor ratio discriminates between reduced synthesis and increased clearance of Von Willebrand factor
    Eikenboom, JCJ
    Castaman, G
    Kamphuisen, PW
    Rosendaal, FR
    Bertina, RM
    THROMBOSIS AND HAEMOSTASIS, 2002, 87 (02) : 252 - 257
  • [46] Characterization of factor VIII von Willebrand factor concentrates using a modified method of von Willebrand factor multimer analysis
    Metzner, HJ
    Hermentin, P
    Cuesta-Linker, T
    Langner, S
    Müller, HG
    Friedebold, J
    HAEMOPHILIA, 1998, 4 : 25 - 32
  • [47] The Course of von Willebrand Factor and Factor VIII Activity in Patients with von Willebrand Disease during Pregnancy
    Delbrueck, Christiane
    Miesbach, Wolfgang
    ACTA HAEMATOLOGICA, 2019, 142 (02) : 71 - 78
  • [48] PHARMACOKINETIC MODELING OF THE VON WILLEBRAND FACTOR - FACTOR VIII INTERACTION IN PERIOPERATIVE VON WILLEBRAND DISEASE PATIENTS
    Bukkems, L. H.
    Heijdra, J.
    de Jager, N.
    Hazendonk, H.
    Fijnvandraat, K.
    Meijer, K.
    Eikenboom, J.
    Laros-van Gorkom, B.
    Leebeek, F.
    Cnossen, M.
    Mathot, R.
    HAEMOPHILIA, 2021, 27 : 147 - 147
  • [49] Population pharmacokinetics of the von Willebrand factor-factor VIII interaction in patients with von Willebrand disease
    Bukkems, Laura H.
    Heijdra, Jessica M.
    de Jager, Nico C. B.
    Hazendonk, Hendrika C. A. M.
    Fijnvandraat, Karin
    Meijer, Karina
    Eikenboom, Jeroen C. J.
    Laros-van Gorkom, Britta A. P.
    Leebeek, Frank W. G.
    Cnossen, Marjon H.
    Mathot, Ron A. A.
    BLOOD ADVANCES, 2021, 5 (05) : 1513 - 1522
  • [50] von Willebrand factor/factor VIII concentrate (Wilate) prophylaxis in children and adults with von Willebrand disease
    Sidonio Jr, Robert F.
    Boban, Ana
    Dubey, Leonid
    Inati, Adlette
    Kiss, Csongor
    Boda, Zoltan
    Lissitchkov, Toshko
    Nemes, Laszlo
    Novik, Dzmitry
    Peteva, Elina
    Taher, Ali T.
    Timofeeva, Margarita Arkadevna
    Vilchevska, Kateryna V.
    Vdovin, Vladimir
    Werner, Sylvia
    Knaub, Sigurd
    Khayat, Claudia Djambas
    BLOOD ADVANCES, 2024, 8 (06) : 1405 - 1414
12345